Submitted by Anonymous (not verified) on 8 November 2023 - 9:41
Human medicines European public assessment report (EPAR): Degarelix Accord, degarelix, Prostatic Neoplasms, Date of authorisation: 29/09/2023, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Degarelix Accord, degarelix, Prostatic Neoplasms, Date of authorisation: 29/09/2023, Status: Authorised